Tirzepatide’s benefits fade for most: Weight and health markers rebound after withdrawal, study findsTirzepatide’s benefits fade for most: Weight and health markers rebound after withdrawal, study finds
Eli Lilly and Company, along with partner institutions in the US and United Kingdom, describe how short-term pharmacologic intervention does not appear to have lasting effects for most tirzepatide patients. People with obesity who lost weight on tirzepatide often regained at least 25% of that loss within a year of stopping treatment, along with reversals Read More
Opinion: Public health should embrace GLP-1 drugs without abandoning obesity preventionOpinion: Public health should embrace GLP-1 drugs without abandoning obesity prevention
Following the White House’s recent announcement of price reductions and expanded coverage for GLP-1 medications like Wegovy and Zepbound, many patients searching for obesity treatments are about to gain access to highly effective options. The implications for U.S. public health are vast. Read the rest… Following the White House’s recent announcement of price reductions Read More
Women ‘traumatised’ by breast cancer treatment at NHS trustWomen ‘traumatised’ by breast cancer treatment at NHS trust
More than 200 patients suffered harm, including unnecessary mastectomies, the BBC has been told.
Is Chronic Cough Another Side Effect of GLP-1 Drugs?Is Chronic Cough Another Side Effect of GLP-1 Drugs?
(MedPage Today) — GLP-1 receptor agonist use was associated with chronic cough regardless of a previous gastroesophageal reflux disease (GERD) diagnosis, a study of over 2 million people with type 2 diabetes suggested. Adults prescribed a GLP… (MedPage Today) — GLP-1 receptor agonist use was associated with chronic cough regardless of a previous gastroesophageal Read More
Medicare negotiated lower prices for 15 drugs, including 71% off Ozempic and WegovyMedicare negotiated lower prices for 15 drugs, including 71% off Ozempic and Wegovy
Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include Ozempic and also drugs to treat asthma, breast cancer and leukemia. (Image credit: Eric Thayer) Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include Ozempic and also drugs to Read More
Medicare announces price cuts for Ozempic and other prescription drugsMedicare announces price cuts for Ozempic and other prescription drugs
The Centers for Medicare and Medicaid Services announced that prices for 15 prescription drugs, including Ozempic, would be lowered under Medicare. NBC News’ Marquise Francis reports on the announcement and what the drugs will now cost. The Centers for Medicare and Medicaid Services announced that prices for 15 prescription drugs, including Ozempic, would be lowered Read More
Medicare Announces Price Cuts for 15 Drugs, Including OzempicMedicare Announces Price Cuts for 15 Drugs, Including Ozempic
Government health officials announced on Tuesday that Medicare recipients will soon pay less for 15 prescription drugs, including popular weight loss medications like Ozempic and Wegovy. The discounts go into effect in 2027 and will save taxpayers about $12 billion. Government health officials announced on Tuesday that Medicare recipients will soon pay less for 15 Read More
Colonoscopy Surveillance and Fatal Cancers; IBS and Night Shifts; AI App for CeliacsColonoscopy Surveillance and Fatal Cancers; IBS and Night Shifts; AI App for Celiacs
(MedPage Today) — While guideline-concordant post-polypectomy colonoscopy surveillance was associated with a reduced risk of incident colorectal cancer (CRC) in a large analysis of U.S. veterans, the study found no reduction in risk for fatal…
On a GLP-1? How to survive holiday meals without derailing your progressOn a GLP-1? How to survive holiday meals without derailing your progress
While being on a GLP-1 can help to accelerate weight loss and regulate blood sugar, it also has the potential to change how people interact socially. As the holidays approach, sitting down for meals with family and lots of indulgent food may be challenging for those taking obesity drugs, as they tend to decrease appetite, Read More
AI tops density in predicting breast cancer riskAI tops density in predicting breast cancer risk
An image-only artificial intelligence (AI) model for predicting the five-year risk of breast cancer provided stronger and more precise risk stratification than breast density assessment, according to a study presented at the annual meeting of the Radiological Society of North America (RSNA).